Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003467879 | SCV004192232 | likely pathogenic | Miyoshi muscular dystrophy 1 | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003738464 | SCV004484797 | pathogenic | Qualitative or quantitative defects of dysferlin | 2024-02-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1264Glnfs*12) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. For these reasons, this variant has been classified as Pathogenic. |